Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Id1 Expression Promotes T Regulatory Cell Differentiation by Facilitating TCR Costimulation.
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study.
Cumulative review of thrombotic microangiopathy, thrombotic thrombocytopenic purpura and hemolytic uremic syndrome reports with SC interferon beta-1a.
Added benefit of fampridine is not proven
HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia.
White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
Keeping cool: use of air conditioning by australians with multiple sclerosis.
Targeting IRF4 in autoimmune diseases.
Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial.
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Suppression of Brain Mast Cells Degranulation Inhibits Microglial Activation and Central Nervous System Inflammation.
Central Nervous System and its Disease Models on a Chip.
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide.
An evidence-based review of natalizumab therapy in the management of Crohn's disease.
Comparison of a 1.5T standard vs. 3T optimized protocols in multiple sclerosis patients.
160 Surgical outcomes of trigeminal neuralgia in patients with multiple sclerosis.
Dual role of Response gene to complement-32 in multiple sclerosis.
Central and Peripheral Nervous System Demyelination Following Mycoplasma Pneumonia Infection With Review of Literature.
No quiet surrender: molecular guardians in multiple sclerosis brain.
Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.
Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE.
Multiple sclerosis and bipolar disorders: The burden of comorbidity and its consequences on quality of life.
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis.

Pages